LETTER TO THE EDITOR Real-Life Perception of Treatment Effectiveness After 24 Weeks of Topical Ruxolitinib in Non-Segmental Vitiligo: Insights From Patient-Reported Outcomes Silvia Alberti-Violetti, Corresponding Author Silvia Alberti-Violetti Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Milan, Italy Correspondence: Silvia Alberti-Violetti (silvia.alberti@unimi.it)...